首页|期刊导航|老年心脏病学杂志（英文版）|Semaglutide ameliorates coronary microembolization-induced injury by suppressing apoptosis and inflammation via the HM-GB1/RAGE/NF-κB p65 pathway
Semaglutide ameliorates coronary microembolization-induced injury by suppressing apoptosis and inflammation via the HM-GB1/RAGE/NF-κB p65 pathwayOA
Semaglutide ameliorates coronary microembolization-induced injury by suppressing apoptosis and inflammation via the HM-GB1/RAGE/NF-κB p65 pathway
Hua-Feng YANG;Hong-Qing LI;Qiang WANG;Xian-Tao WANG;Lang LI
Cardiac Surgery Intensive Care Unit,The First Affiliated Hospital of Guangxi Medical University,Nanning,ChinaDe-partment of Cardiology,The First Affiliated Hospital of Guangxi Medical University,Nanning,ChinaDe-partment of Cardiology,The First Affiliated Hospital of Guangxi Medical University,Nanning,ChinaDe-partment of Cardiology,The First Affiliated Hospital of Guangxi Medical University,Nanning,ChinaDe-partment of Cardiology,The First Affiliated Hospital of Guangxi Medical University,Nanning,China
《老年心脏病学杂志（英文版）》 2026 (2)
83-99,17
评论